Impact of interactions between risk alleles on clinical endpoints in hypertension.
OBJECTIVE
Impairment of the renin-angiotensinogen-aldosterone system (RAAS), one of the characteristics of essential hypertension (EH), imbalances vascular homeostasis. Despite inconsistent reports on individual single nucleotide polymorphisms (SNPs) as a major predictor of EH, interactions among RAAS genetic variants are rarely investigated.


METHODS
Using SNP markers, we studied potential interactions between angiotensin 1 converting enzyme (ACE), angiotensinogen (AGT), angiotensin II-type 1 receptor (AGTR1), and α adducin (ADD1) variants and their correlation with clinical endpoints in 545 individuals with hypertension and 400 age- and ethnicity-matched unrelated controls. Generalised multifactor dimensionality reduction (GMDR) analysis identified the models for genotype interaction.


RESULTS
Although the results on single genes were significant, gene-gene interactions were more reliable and promising as markers in predisposing hypertension. The best models to represent association of multi-locus interactions with augmented hypertension susceptibility were: (a) within gene 4-locus model comprised of AGT SNPs -217G/A, -20A/C, -6G/A and 235M/T (p=0.022, OR 6.1); and (b) between genes 5-locus model comprised of AGT -217G/A, -20A/C, -6G/A, 235M/T and ACE I/D (p=0.05, OR 4.6). Stratification of 4- and 5-locus GMDR models on the basis of risk alleles from ≤1 to ≥7 increased the ORs from 2.8 to 36.1 and from 0.9 to 16.1, respectively. Moreover, compared to ≤1 risk alleles the ≥7 interacting risk alleles in both 4- and 5-locus models showed an increment of 14.2% and 11.1% in systolic blood pressure, 7.7% and 1.1% in diastolic blood pressure, and 10.5% and 5.1% in mean arterial pressure, respectively, in patients.


CONCLUSIONS
Interactions among the genetic loci of RAAS components may be used as a predictor for susceptibility to hypertension.
Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, New Delhi, Delhi, India; Academy of Scientific and Innovative Research, New Delhi, Delhi, India.
Samantha
S
Kohli
Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, New Delhi, Delhi, India; Division of Pulmonary Sciences and Critical Care Medicine, School of Medicine, University of Colorado, Denver, USA.
Rahul
R
Kumar
Department of Cardiology , G.B. Pant Hospital , New Delhi, Delhi , India.
Mohit
M
Gupta
Department of Cardiology , G.B. Pant Hospital , New Delhi, Delhi , India.
Sanjay
S
Tyagi
Genomics and Molecular Medicine, CSIR-Institute of Genomics and Integrative Biology, New Delhi, Delhi, India; Academy of Scientific and Innovative Research, New Delhi, Delhi, India.
M A Qadar
MA
Pasha
GENETICS; HYPERTENSION